Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: January 14, 2025
Reporting Period: This filing reports on events occurring on January 14, 2025, specifically regarding upcoming investor presentations.
Key Financial Metrics
This Form 8-K does not contain specific financial statements, revenue figures, profit data, cash flow, margins, debt levels, or liquidity metrics. The filing serves as a disclosure notice rather than a financial report.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing discloses the intent of executive officers to utilize an investor presentation (Exhibit 99.1) for upcoming meetings with investors and analysts.
Guidance, Outlook, and Risks
- Management Commentary: Executive officers plan to present material from Exhibit 99.1 (OrthoPediatrics Corp. Investor Presentation dated January 2024) to investors and analysts.
- Regulatory Status: The information provided in Item 7.01 and Exhibit 99.1 is furnished pursuant to Regulation FD and is not deemed "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless expressly stated.
- Risks and Contingencies: No specific risks or contingencies are detailed in this filing text.
Investor Verification Checklist
- Verify the content of Exhibit 99.1 (Investor Presentation dated January 2024) referenced in this filing for actual financial data and strategic outlook.
- Confirm the dates and details of the upcoming investor presentations mentioned by executive officers.
- Note that the financial data in the referenced presentation is from January 2024 and may not reflect the current status as of January 2025.